Therapeutic plasmapheresis

Seminars in Veterinary Medicine and Surgery-Small Animal

Volumn 12, Issue 3, 1997, Pages 170-177

  Bartges, Joseph W ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ANIMAL; ANIMAL DISEASE; ANTIGEN ANTIBODY COMPLEX; BLOOD; DOG; DOG DISEASE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; METHODOLOGY; MULTIPLE MYELOMA; MYASTHENIA GRAVIS; PARAPROTEINEMIA; PLASMAPHERESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ANEMIA, HEMOLYTIC; ANIMALS; ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; DOG DISEASES; DOGS; HUMANS; IMMUNE SYSTEM DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE MYELOMA; MYASTHENIA GRAVIS; PARAPROTEINEMIAS; PLASMAPHERESIS; THROMBOCYTOPENIA;

EID: 0031201725     PISSN: 08820511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-2867(97)80030-8     Document Type: Article

References (85)

1. Jones JV: Plasmapheresis in the treatment of immunological disease. Clin Immunol Allergy 5:13-32, 1985
2. Wenz B, Barland P: Therapeutic intensive plasmapheresis. Semin Hematol 18:147-162, 1981
3. Klein HG: Apheresis in transition. Curr Stud Hematol Blood Transfus 57:1-9, 1990
4. Nand S, Molokie R: Therapeutic plasmapheresis and protein A immunoadsorption in malignancy: A brief review. J Clin Apheresis 5:206-212, 1990
5. Nose Y, Gurland HJ, Klein HG, et al: Plasmapheresis and cytapheresis. Trans Am Soc Artif Intern Organs 28:631-638, 1982
6. Linker C: Plasmapheresis in clinical medicine. West J Med 138:60-69, 1983
7. Patten E: Therapeutic plasmapheresis and plasma exchange. Crit Rev Clin Lab Sci 23:147-175, 1986
8. Isbister JP: The risk/benefit equation for therapeutic plasma exchange. Curr Stud Hematol Blood Transfus 57:10-30, 1990
9. Heininger K, Gibbels E, Besinger UA, et al: Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy. Prog Clin Biol Res 337:275-281, 1990
10. Clark WF, Dau PC, Euler HH, et al: Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG). J Clin Apheresis 6:40-47, 1991
11. Sawada K, Malchesky PS, Nose Y: Available removal systems: State of the art. Curr Stud Hematol Blood Transfus 57:51-113, 1990
12. Buckner CD, Clift RA, Thomas ED: Plasma exchange with the continuous flow centrifuge, in Goldman JM, Lowenthal RM (eds): Leucocytes: Separation, Collection and Transfusion, vol 200. London, Academic Press, 1975, pp 578-580
13. Jones JV, McLeod BC: Centrifugal separation of plasma: Techniques and applications. Trans Am Soc Artif Intern Organs 27:351-355, 1981
14. Oon CJ, Hobbs JR: Clinical applications of the continuous flow blood separator machine. Clin Exp Immunol 20:1-16, 1975
15. Pineda AA, Brzica S Jr, Taswell HF: Continuous- and semicontinuous-flow blood centrifugation systems: Therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis. Transfusion 17:407-416, 1977
16. Samtleben W, Randerson DH, Blumenstein M, et al: Membrane plasma exchange: Principles and application techniques. J Clin Apheresis 2:163-169, 1984
17. Busnach G, Dal-Col A, Brando B, et al: Different cascade filtration operating modalities in clinical use. Int J Artif Organs 11:493-496, 1988
18. Euler HH, Schmitz N, Loffler H: Plasmapheresis in paraproteinemia. Blut 50:321-330, 1985
19. Hoffkes HG, Heemann UW, Teschendorf C, et al: Hyperviscosity syndrome: Efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenstrom's type. Clin Nephrol 43:335-358, 1995
20. Matus RE, Leifer CE, Gordon BR, et al: Plasmapheresis and chemotherapy of hyperviscosity syndrome associated with monoclonal gammopathy in the dog. J Am Vet Med Assoc 183:215-218, 1983
21. Shull RM, Osborne CA, Barrett RE: Serum hyperviscosity syndrome associated with IgA multiple myeloma in two dogs. J Am Anim Hosp Assoc 14:58-62, 1978
22. Klausner JS, Poffenbarger EM, Matus RE: Therapeutic hemapheresis, in Kirk RW (ed): Current Veterinary Therapy IX. Philadelphia, PA, Saunders, 1986, pp 110-114
23. Matus RE, Leifer CE, Hurvitz AI: Use of plasmapheresis and chemotherapy for treatment of monoclonal gammopathy associated with Ehrlichia canis infection in a dog. J Am Vet Med Assoc 190:1302-1304, 1987
24. Forrester SD, Greco DS, Relford RL: Serum hyperviscosity syndrome associated with multiple myeloma in two cats. J Am Vet Med Assoc 200:79-82, 1992
25. Solling K, Solling J: Clearances of Bence-Jones proteins during peritoneal dialysis or plasmapheresis in myelomatosis associated with renal failure. Contrib Nephrol 68:259-262, 1988
26. Matus RE, Schrader LA, Leifer CE, et al: Plasmapheresis as adjuvant therapy for autoimmune hemolytic anemia in two dogs. J Am Vet Med Assoc 186:691-693, 1985
27. Wall BA, Weinblatt ME, Agudelo CA: Plasmapheresis in the treatment of resistant thrombocytopenia in systemic lupus erythematosus. South Med J 75:1277-1278, 1982
28. Porter CC, Ruley EJ, Luban NL, et al: Accelerated recovery from immune-mediated thrombocytopenia with plasmapheresis. Am J Med 79:765-768, 1985
29. Sakamoto H, Takaoka T, Usami M, et al: Apheresis: Clinical response to patients unresponsive to conventional therapy. Trans Am Soc Artif Intern Organs 31:704-710, 1985
30. Engel AG: Myasthenia gravis and myasthenic syndromes. Ann Neurol 16:519-534, 1984
31. Ichikawa M, Koh CS, Hata Y, et al: Immunoadsorption plasmapheresis for severe generalised myasthenia gravis. Arch Dis Child 69:236-238, 1993
32. Berta E, Confalonieri P, Simoncini O, et al: Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis. Int J Artif Organs 17:603-608, 1994
33. Bartges JW, Klausner JS, Bostwick EF, et al: Clinical remission following plasmapheresis and corticosteroid treatment in a dog with acquired myasthenia gravis. J Am Vet Med Assoc 196:1276-1278, 1990
34. Shoenfeld Y, George J, Peter JB: Guillain-Barre as an autoimmune disease. Int Arch Allergy Immunol 109:318-326, 1996
35. England JD: Guillain-Barre syndrome. Annu Rev Med 41:1-6, 1990
36. Wuest D, Goldfinger D: Plasmapheresis in the treatment of acute relapsing inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection: A case report. J Clin Apheresis 4:149-151, 1988
37. McKhann GM, Griffin JW, Cornblath DR, et al: Plasmapheresis and Guillain-Barre syndrome: Analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 23:347-353, 1988
38. Boumpas DT, Austin HR, Fessier BJ, et al: Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122:940-950, 1995
39. Euler HH, Schroeder JO, Harten P, et al: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37:1784-1794, 1994
40. Matus RE, Scott RC, Saal S, et al: Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog. J Am Vet Med Assoc 182:499-502, 1983
41. Matus RE, Gordon BR, Leifer CE, et al: Plasmapheresis in five dogs with systemic immune-mediated disease. J Am Vet Med Assoc 187:595-599, 1985
42. Salinas FA, Wee KH, Silver HK: Immune complexes and human neoplasia. Biomed Pharmacother 37:211-218, 1983
43. Israel L, Edelstein R, Mannoni P, et al: Plasmapheresis in patients with disseminated cancer: Clinical results and correlation with changes in serum protein. The concept of "nonspecific blocking factors." Cancer 40:3146-3154, 1977
44. Seder RH, Vaughan CW, Oh SK, et al: Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancer. Cancer 60:318-325, 1987
45. Graus F, Vega F, Delattre JY, et al: Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536-540, 1992
46. Klausner JS, Miller WJ, O'Brien TD, et al: Effects of plasma treatment with purified protein A and Staphylococcus aureus Cowan I on spontaneous animal neoplasms. Cancer Res 45:1263-1266, 1985
47. Gordon BR, Matus RE, Saal SD, et al: Protein A independent tumoricidal responses following extracorporeal perfusion of plasma over Staphylococcus aureus. J Natl Cancer Inst 70:1127-1131, 1983
48. Dennis M Jr, Schmer G, Rastelli LN, et al: Successful long-term use of a plasmapheresis reactor system in dogs with lymphoma. Trans Am Soc Artif Intern Organs 29:744-748, 1983
49. Roujeau JC: Plasmapheresis therapy of pemphigus and bullous pemphigoid. Semin Dermatol 7:195-200, 1988
50. Tan-Lim R, Bystryn JC: Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol 22:35-40, 1990
51. Takahashi T, Asanuma Y, Kato T, et al: On-line plasma exchange for sepsis in neonates and infants. Tohoku J Exp Med 159:249-256, 1989
52. Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 14:94-101, 1996
53. Cornblath DR: Treatment of the neuromuscular complications of human immunodeficiency virus infection. Ann Neurol 23:S88-S91, 1988
54. Dalakas MC, Cupler EJ: Neuropathies in HIV infection. Baillieres Clin Neurol 5:199-218, 1996
55. Rogna S, Puppo F, Stagnaro R, et al: Plasma exchange plus immunoglobulins for treatment of hypergammaglobulinaemic patients with AIDS and AIDS-related complex (ARC). Cancer Detect Prev 12:273-276, 1988
56. Nair JM, Bellevue R, Bertoni M, et al: Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex: A report of two cases. Ann Intern Med 109:209-212, 1988
57. Bosch T, Gurland HJ: Overview: Techniques and indications of LDL-apheresis. Biomater Artif Cells Immobilization Biotechnol 19:1-18, 1991
58. Matsuda Y, Sueoka A, Nose Y: An effective LDL removal filter for the treatment of hyperlipidemia. Artif Organs 19:129-134, 1995
59. Hugou I, Janvier G, Bordenave L, et al: A new apheresis system using a copolymer (polyvinyl alcohol triethylene glycol diacrylate) for removal of LDL from dog whole blood. J Biomater Sci Polym Ed 3:419-431, 1992
60. Cohen LB, Ambinder EP, Wolke AM, et al: Role of plasmapheresis in primary biliary cirrhosis. Gut 26:291-294, 1985
61. Fryden A, Weiland O, Martensson J: Successful treatment of hepatic coma probably caused by acute infectious hepatitis with balanced solution of amino acids. Scand J Infect Dis 14:177-180, 1982
62. Radchenko VG: Plasmapheresis efficacy in the treatment of patients with chronic cholestatic hepatitis and primary biliary liver cirrhosis. Lik Sprava:160-163, 1995
63. Marner B, Lernmark A, Ludvigsson J, et al: Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis. Diabetes Res 2:231-236, 1985
64. Charlton B, Cooper SG, Brown AS, et al: A new application of plasma exchange in insulin dependent diabetes mellitus. Biomed Pharmacother 39:19-22, 1985
65. Vannini P, Forlani G, Giangiulio S, et al: Possible effectiveness of plasmapheresis and immunosuppressive therapy in reversing subcutaneous insulin resistance: A case report. Diabetes Metab 15:98-101, 1989
66. Micic D, Brkic S, Kendereski A, et al: Immunological resistance to human biosynthetic insulin: Effects of immunosuppression and plasmapheresis. Diabetes Res Clin Pract 19:83-89, 1993
67. Braithwaite SS, Brooks MH, Collins S, et al: Plasmapheresis: An adjunct to medical management of severe hyperthyroidism. J Clin Apheresis 3:119-123, 1986
68. De-Rosa G, Testa A, Menichella G, et al: Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica 1:72-74, 1991
69. Binimelis J, Bassas L, Marruecos L, et al: Massive thyroxine intoxication: Evaluation of plasma extraction. Intensive Care Med 13:33-38, 1987
70. Erickson SB, Kurtz SB, Donadio J Jr, et al: Use of combined plasmapheresis and immunosuppression in the treatment of Goodpasture's syndrome. Mayo Clin Proc 54:714-720, 1979
71. Wiseman KC: New insights on Goodpasture's syndrome. Anna J 20:17-26, 1993
72. Coppo R, Basolo B, Giachino O, et al: Plasmapheresis in a patient with rapidly progressive idiopathic IgA nephropathy: Removal of IgA-containing circulating immune complexes and clinical recovery. Nephron 40:488-490, 1985
73. Appel GB, Valeri A: The course and treatment of lupus nephritis. Annu Rev Med 45:525-537, 1994
74. Mason PD, Pusey CD: Plasma exchange in nephrological disease. Curr Stud Hematol Blood Transfus 57:152-166, 1990
75. Adams MB, Kauffman H Jr, Hebert LA, et al: Plasmapheresis in the treatment of renal allograft rejection. Proc Clin Dial Transplant Forum 9:252-255, 1979
76. Hodge EE, Klingman LL, Koo AP, et al: Pretransplant removal of anti-HLA antibodies by plasmapheresis and continued suppression on cyclosporine-based therapy after heart-kidney transplant. Transplant Proc 26:2750-2751, 1994
77. Muczynski KA: Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I. Am J Nephrol 15:446-449, 1995
78. Uldry PA, Steck AJ: Plasma exchange in neurology. Curr Stud Hematol Blood Transfus 57:167-183, 1990
79. Sany J: Immunological treatment of rheumatoid arthritis. Clin Exp Rheumatol 5:81-88, 1990
80. Hamblin TJ: Apheresis in rheumatoid arthritis. Int J Artif Organs 7:229-230, 1984
81. Asanuma Y, Malchesky PS, Smith JW, et al: Removal of protein-bound toxins from critical care patients. Clin Toxicol 17:571-581, 1980
82. Jones JS, Dougherty J: Current status of plasmapheresis in toxicology. Ann Emerg Med 15:474-482, 1986
83. Li PK, Lai KN: Active therapeutic approaches to drug intoxication. Adverse Drug React Acute Poisoning Rev 7:55-73, 1988
84. Winchester JF: Poisoning: Is the role of the nephrologist diminishing? Am J Kidney Dis 13:171-183, 1989
85. Tsatsakis AM, Perakis K, Koumantakis E: Experience with acute paraquat poisoning in Crete. Vet Hum Toxicol 38:113-117, 1996